Human papillomavirus. Often harmless but in some cases carcinogenic

Prescrire International

Volumn 16, Issue 89, 2007, Pages 115-119

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

AGE DISTRIBUTION; CANCER GRADING; CANCER RISK; CANCER SCREENING; CONDYLOMA; DIGESTIVE SYSTEM CANCER; GENITAL TRACT CANCER; GENITAL TRACT INFECTION; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOSUPPRESSIVE TREATMENT; MALIGNANT TRANSFORMATION; NONHUMAN; RESPIRATORY TRACT CANCER; REVIEW; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; SKIN CANCER; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VERRUCA VULGARIS; VIRAL CONTAMINATION; VIRAL SKIN DISEASE; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; WART VIRUS; ANUS TUMOR; ARTICLE; DISEASE TRANSMISSION; FEMALE; GENETICS; MALE; METABOLISM; NEOPLASM; PAPILLOMA VIRUS; SKIN TUMOR; UROGENITAL TRACT TUMOR; UTERINE CERVIX TUMOR; VIROLOGY;

ANUS NEOPLASMS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOSUPPRESSION; MALE; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SEXUALLY TRANSMITTED DISEASES, VIRAL; SKIN NEOPLASMS; UROGENITAL NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 34447284970     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Orth G et al. "The human papillomaviruses" Bull cancer 1978; 65: 151-164.
2. International Agency for Research on Cancer (IARC) "Human papillomavirus (HPV) infection". In: "LARC monographs on the evaluation of carcinogenic risks to human. Human papillomavirus" World Health Organization 1995: 35-86.
3. International Agency for Research on Cancer (IARC) "Studies of cancer in humans". In: "IARC monographs on the evaluation of carcinogenic risks to human. Human papillomavirus" World Health Organization 1995: 87-232.
4. Favre M et al. "Human papillomaviruses: general features" Clin Dermatol 1997; 15 (2): 181-198.
5. Douvier S and Pothier P "Papillomavirus". In: Denis F "Les virus transmissibles de la mère à l'enfant" John libbey Eurotext, Paris 1999: 277-288.
6. Beby-Defaux A "Les papillomavirus humains". In: Mamette A "Virologie médicale" Presses Universitaires de Lyon, Lyon 2002: 477-484.
7. Brentjens MH et al. "Human papillomavirus: a review" Dermatol Clin 2002; 20: 315-331.
8. Monsonego J "Cancer du col en France et dans le monde". In: Monsonego J "Infections à papillomavirus. État des connaissances, pratiques et prévention vaccinale" Springer-Verlag France, Paris 2006: 47-63.
9. Mubñoz N et al. "HPV in the etiology of human cancer" Vaccine 2006; 24 (suppl. 3): 1-10.
10. Leigh IM et al. "Human papilloma viruses and cancers of the skin and oral mucosa". In: Goedert JJ "Infectious causes of cancer: targets for intervention" Humana Press, Totowa 2000: 289-309.
11. Fakhry C and Gillison ML "Clinical implications of human papillomavirus in head and neck cancers" J Clin Oncol 2006; 24 (17): 2606-2611.
12. Stevens MP et al. "Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia" Int J Gynecol Cancer 2006; 16: 1017-1024.
13. Jablonska S et al. "Cutaneous warts" Clin Dermatol 1997; 15 (3): 309-319.
14. Lacey CJN et al. "Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease" Vaccine 2006; 24 (suppl. 3): 35-41.
15. Winter RL and Koutsky LA "The epidemiology of human papallomavirus infections". In: Rohan TE and Shah KV "Cervical cancer: from etiology to prevention" Kluwer Academic Publishers, Dordrecht 2004: 143-187.
16. Bosch FX et al. "Epidemiology of human papillomavirus infections and associations with cervical cancer new opportunities for prevention". In: Campo S "Papillomavirus research: from natural history to vaccines and beyond" Caister Academic Press, Wymondham, 2006: 229-253.
17. Burchell AN et al. "Epidemiology and transmission dynamics of genital HPV infection" Vaccine 2006; 24 (suppl. 3): 52-61.
18. Frazer IH et al. "Advances in prevention of cervical cancer and other human papillomavirus-related diseases" Pediatr Infect Dis J2006; 25 (2 suppl.): 65-81.
19. Stone KM et al. "Seroprevalence of human papillomavirus type 16 infection in the United States" J Infect Dis 2002; 186: 1396-1402.
20. Clavel C et al. "Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women" Br J Cancer 2001; 84 (12): 1616-1623.
21. Boulanger JC et al. "Épidémiologie de l'infection à HPV" Gynecol Obstet Fertil 2004, 32 (3): 218-3.
22. Dalstein V et al. "Detection of cervical precancer and cancer in a hospital population: benefits of testing for human papillomavirus" Eur J Cancer 2004, 40 (8): 1225-1232.
23. Strauss S et al. "Contamination of environmental surfaces by genital human papillomaviruses" Sex Transm Infect 2002; 78: 135-138.
24. Bouwes Bavinck JN and Berkhout RJM "HPV infections and immunosuppression" Clin Dermatol 1997; 15: 427-437.
25. Palefsky JM "Cutaneous and genital HPV-associated lesions in HIV-infected patients" Clin Dermatol 1997; 15 (3): 439-447.
26. Palefsky JM and Holly EA "Immunosuppression and co-infection with HIV" J Natl Cancer Inst Monogr 2003; (31): 41-46.
27. Ognenovski VM "Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide" J Rheumatol 2004; 31 (9): 1763-1767.
28. Palefsky JM "Anogenital squamous cell cancer and its precursors. Natural history, diagnosis and treatment". In: Goedert JJ "Infectious causes of cancer: targets for intervention" Humana Press, Totowa 2000: 263-287.
29. Spano JP et al. "Cancer et infection à papillomavirus humain" Bull Cancer 2005; 92 (1): 59-64.
30. Spence AR et al. "The role of human papillomavirus in cancer. Evidence to date" Am J Cancer 2005; 4 (1): 49-64.
31. Moscicki AB et al. "Updating the natural history of HPV and anogenital cancer" Vaccine 2006; 24 (suppl. 3): 42-51.
32. Monsonego J "Prévention du cancer du col utérin: enjeux et perspectives de la vaccination antipapillomavirus" Gynecol Obstet Fertil 2006; 34: 189-201.
33. Duport N "Données épidémiologiques sur le cancer du col de l'utérus. État des connaissances" summary, Institut de veille sanitaire, October 2006: 25 pages.
34. Monsonego, J "Infections génitales à HPV. Bases fondamentales". In: Monsonego J "Cancer du col en France et dans le monde" Springer-Verlag France, Paris 2006:47-63.
35. Bosch FX and de Sanjosé S "Human papillomavirus and cervical cancer. Burden and assessment of causality" J Natl Cancer Inst Monogr 2003; (31): 3-13.
36. Burd EM "Human papillomavirus and cervical cancer" Clin Microbiol Rev 2003; 16 (1): 1-17.
37. Franco EL et al. "The epidemiology of cervical cancer" Cancer J2003; 9: 348-359.
38. Bosch FX "The etiology of squamous cell cervical cancer". In: Rohan TE et Shah KV "Cervical cancer: from etiology to prevention" Kluwer Academic Publishers, Dordrecht 2004: 191-216.
39. Miller AB "The natural history of cervical cancer". In: Rohan TE and Shah KV "Cervical cancer: from etiology to prevention" Kluwer Academic Publishers, Dordrecht 2004: 61-78.
40. Tjalma WAA et al. "Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix" Best Pract Res Clin Obstet Gynaecol 2005; 19 (4): 469-483.
41. Snijders PJF et al. "HPV-mediated cervical carcinogenesis: concepts and clinical implications" J Pathol 2006; 208: 152-164.
42. Schiffman M and Kjaer SK "Natural history of anogenital human papillomavirus infection and neoplasia" J Natl Cancer Inst Monogr 2003; (31): 14-19.
43. Vaccarella S et al. "Sexual behaviour, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys" Cancer Epidemiol Biomarkers Prev 2006; 15 (2): 326-333.
44. Castellsagué X and Muñoz N "Cofactors in human papillomavirus carcinogenesis. Role of parity, oral contraceptives, and tobacco smoking" J Natl Cancer Inst Monogr 2003; (31): 20-28.
45. Castle PE and Giuliano AR "Genital tract infections, cervical inflammation, and antioxydant nutrients - Assessing their roles as human papillomavirus cofactors" J Natl Cancer Inst Monogr 2003; (31): 29-34.
46. Kelly RW "Seminal plasma immunosuppressive activity: the Achilles heel of reproduction" Int J Androl 1991; 14: 243-247.
47. Tolstrup J et al. "The role of smoking and alcohol intake in the development of high-grade squamous intraepithelial lesions among high-risk HPV-positive women" Acta Obstet Gynecol Scand 2006; 85 (9): 1114-1119.
48. Maxwell Parkin D and Bray F "The burden of HPV-related cancers" Vaccine 2006; 24 (suppl. 3): 11-25.
49. Gastrell FH and McConnell DT "Human papillomavirus and vulval intra-epithelial neoplasia" Best Pract Res Clin Obstet Gynaecol 2001; 15 (5): 769-782.
50. Daling JR et al. "A population-based study of squamous cell vaginal cancer: HPV and cofactors" Gynecol Oncol 2002; 84: 263-270.
51. Benabderrahmane D and Abramowitz L "Infection HPV et condylomes anaux. États des lieux en 2006: description, prévalence et prise en charge" Hépato-Gastro 2006; 13 (3): 195-205.
52. Castellsagué X et al. "Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention" J Natl Cancer Inst 2006; 98 (5): 303-315.
53. Fox PA "Human papillomavirus and anal intraepithelial neoplasia" Curr Opin Infect Dis 2006; 19: 62-66.
54. Partridge JM and Koutsky LA "Genital human papillomavirus in men" Lancet Infect Dis 2006, 6: 21-31.
55. Palefsky JM and Barrasso R "HPV infection and disease in men" Obstet Gynecol Clin North Am 1996; 23 (4): 895-916.
56. Majewski S et al. "Epidermodysplasia verruciformis Immunological and nonimmunological surveillance mechanisms: roles in tumor progression" Clin Dermatol 1997; 15 (3): 321-334.
57. Pfister H "Human papillomavirus and skin cancer" J Natl Cancer Inst Monogr 2003; (31): 52-56.
58. Akgül B et al. "HPV-associated skin disease" J Pathol 2006; 208: 165-175.
59. Aaltonen LM et al. "Human Papillomavirus in larynx" Laryngoscope 2002; 112: 700-707.
60. Syrjänen KJ "HPV infections and lung cancer" J Clin Pathol 2002; 55: 885-891.
61. Hobbs CGL et al. "Human papillomavirus and head and neck cancer a systematic review and metaanalysis" Clin Otolaryngol 2006; 31: 259-266.
62. Syrjäinen K "HPV and oesophageal carcinoma". In: Campo S "Papillomavirus research: from natural history to vaccines and beyond" Caister Academic Press, Wymondham, 2006: 229-253.